BriaCell Therapeutics Corp. - Common Shares (BCTX) SEC filings
BCTX SEC filings moved a median of -0.17% by the close. BCTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the BCTX overview →
72 measured BCTX SEC filing events.
Where these BCTX SEC filings landedvs 72 measured BCTX SEC filing reactions
| Middle 50% of BCTX SEC filing reactions | -5.35% to +4.22% |
|---|---|
| Median reaction (to close) | -0.17% |
| Measured reactions | 72 |
Point-in-time · zero look-ahead
Half of the 72 BCTX SEC filing events with a measured close landed between -5.35% and +4.22%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K BriaCell Therapeutics For: Jun 26 | SEC filing · Form 8-K | -0.64% | -0.64% | |
| Form 10-Q BriaCell Therapeutics For: Apr 30 | SEC filing · Form 10-Q | +1.00% | -4.32% | |
| Form 8-K BriaCell Therapeutics For: May 31 | SEC filing · Form 8-K | -1.49% | +0.92% | |
| Form 8-K BriaCell Therapeutics For: Mar 31 | SEC filing · Form 8-K | +0.00% | -0.24% | |
| Form 10-Q BriaCell Therapeutics For: Jan 31 | SEC filing · Form 10-Q | +0.52% | +13.61% | |
| Form 8-K BriaCell Therapeutics For: Mar 05 | SEC filing · Form 8-K | +2.39% | +1.33% | |
| Form 8-K BriaCell Therapeutics For: Feb 18 | SEC filing · Form 8-K | -2.56% | -3.59% | |
| Form DEF 14A BriaCell Therapeutics For: Feb 12 | SEC filing · Form DEF | +1.23% | -0.24% | |
| Form 8-K BriaCell Therapeutics For: Jan 13 | SEC filing · Form 8-K | -0.90% | -4.67% | |
| Form EFFECT BriaCell Therapeutics | SEC filing · Form EFFECT | +5.83% | +1.25% | |
| Form 8-A12B BriaCell Therapeutics | SEC filing · Form 8-A12B | -1.07% | +7.82% | |
| Form CERT BriaCell Therapeutics | SEC filing · Form CERT | +5.83% | +1.25% | |
| Form S-1MEF BriaCell Therapeutics | SEC filing · Form S-1MEF | +5.83% | +1.25% | |
| Form 8-K BriaCell Therapeutics For: Dec 29 | SEC filing · Form 8-K | +0.00% | +6.90% | |
| Form S-1 BriaCell Therapeutics | SEC filing · Form S-1 | -3.77% | +9.58% | |
| Form 10-Q BriaCell Therapeutics For: Oct 31 | SEC filing · Form 10-Q | -0.97% | -7.38% | |
| Form 8-K BriaCell Therapeutics For: Nov 28 | SEC filing · Form 8-K | +4.87% | +4.22% | |
| Form 10-K BriaCell Therapeutics For: Jul 31 | SEC filing · Form 10-K | +0.00% | +3.18% | |
| Form 8-K BriaCell Therapeutics For: Aug 21 | SEC filing · Form 8-K | +2.78% | +8.74% | |
| Form S-8 BriaCell Therapeutics | SEC filing · Form S-8 | -0.40% | +2.62% | |
| Form 8-K BriaCell Therapeutics For: Jul 15 | SEC filing · Form 8-K | +1.19% | +0.17% | |
| Form EFFECT BriaCell Therapeutics | SEC filing · Form EFFECT | +3.15% | +1.49% | |
| Form S-1/A BriaCell Therapeutics | SEC filing · Form S-1 | +0.49% | +0.00% | |
| Form S-1/A BriaCell Therapeutics | SEC filing · Form S-1 | -0.07% | -0.24% | |
| Form S-1 BriaCell Therapeutics | SEC filing · Form S-1 | +3.10% | -6.64% | |
| Form 8-K BriaCell Therapeutics For: Jun 16 | SEC filing · Form 8-K | -0.95% | -1.27% | |
| Form 10-Q BriaCell Therapeutics For: Apr 30 | SEC filing · Form 10-Q | +2.57% | +0.32% | |
| Form 8-K BriaCell Therapeutics For: Apr 24 | SEC filing · Form 8-K | -2.23% | -7.08% | |
| Form EFFECT BriaCell Therapeutics | SEC filing · Form EFFECT | +6.88% | +9.47% | |
| Form 8-A12B BriaCell Therapeutics | SEC filing · Form 8-A12B | -0.73% | -7.51% | |
| Form CERT BriaCell Therapeutics | SEC filing · Form CERT | +6.88% | +9.47% | |
| Form S-1MEF BriaCell Therapeutics | SEC filing · Form S-1MEF | +6.88% | +9.47% | |
| Form S-1/A BriaCell Therapeutics | SEC filing · Form S-1 | -7.37% | -35.58% | |
| Form S-1 BriaCell Therapeutics | SEC filing · Form S-1 | +8.09% | +15.53% | |
| Form 10-Q BriaCell Therapeutics For: Jan 31 | SEC filing · Form 10-Q | +1.98% | -2.82% | |
| Form 8-K BriaCell Therapeutics For: Mar 12 | SEC filing · Form 8-K | +1.98% | -2.82% | |
| Form 8-K BriaCell Therapeutics For: Feb 12 | SEC filing · Form 8-K | +0.00% | +13.28% | |
| Form 8-K BriaCell Therapeutics For: Feb 05 | SEC filing · Form 8-K | -0.73% | -8.58% | |
| Form 8-K BriaCell Therapeutics For: Feb 03 | SEC filing · Form 8-K | -1.56% | -9.60% | |
| Form 8-K BriaCell Therapeutics For: Jan 24 | SEC filing · Form 8-K | -6.59% | +6.50% | |
| Form 8-K BriaCell Therapeutics For: Jan 03 | SEC filing · Form 8-K | -2.58% | -8.44% | |
| Form DEFA14A BriaCell Therapeutics | SEC filing · Form DEFA14A | -2.58% | -8.44% | |
| Form DEF 14A BriaCell Therapeutics For: Dec 17 | SEC filing · Form DEF | -1.54% | -5.23% | |
| Form 10-Q BriaCell Therapeutics For: Oct 31 | SEC filing · Form 10-Q | +3.27% | +11.12% | |
| Form 8-K BriaCell Therapeutics For: Dec 12 | SEC filing · Form 8-K | +3.27% | +11.12% | |
| Form 8-K BriaCell Therapeutics For: Dec 11 | SEC filing · Form 8-K | -7.54% | -6.45% | |
| Form 8-K BriaCell Therapeutics For: Nov 23 | SEC filing · Form 8-K | -5.17% | +4.49% | |
| Form 8-K BriaCell Therapeutics For: Nov 01 | SEC filing · Form 8-K | +1.15% | -0.76% | |
| Form 10-K BriaCell Therapeutics For: Jul 31 | SEC filing · Form 10-K | -3.32% | -7.52% | |
| Form 8-K BriaCell Therapeutics For: Oct 01 | SEC filing · Form 8-K | -0.12% | -0.11% | |
| Form 8-K BriaCell Therapeutics For: Oct 01 | SEC filing · Form 8-K | +3.80% | +27.83% | |
| Form 8-K BriaCell Therapeutics For: Sep 11 | SEC filing · Form 8-K | -1.48% | -11.03% | |
| Form 8-K BriaCell Therapeutics For: Sep 09 | SEC filing · Form 8-K | -7.98% | -65.96% | |
| Form 8-K BriaCell Therapeutics For: Aug 22 | SEC filing · Form 8-K | -2.18% | -5.93% | |
| Form 8-K BriaCell Therapeutics For: Jul 18 | SEC filing · Form 8-K | -3.84% | +1.02% | |
| Form 8-K BriaCell Therapeutics For: Jul 03 | SEC filing · Form 8-K | +0.97% | +2.91% | |
| Form 10-Q BriaCell Therapeutics For: Apr 30 | SEC filing · Form 10-Q | +0.00% | +4.22% | |
| Form 8-K BriaCell Therapeutics For: Jun 14 | SEC filing · Form 8-K | +0.00% | +4.22% | |
| Form 8-K BriaCell Therapeutics For: May 14 | SEC filing · Form 8-K | -4.03% | +0.00% | |
| Form 8-K BriaCell Therapeutics For: Apr 01 | SEC filing · Form 8-K | +1.08% | +3.97% | |
| Form 10-Q BriaCell Therapeutics For: Jan 31 | SEC filing · Form 10-Q | -1.78% | -3.56% | |
| Form EFFECT BriaCell Therapeutics | SEC filing · Form EFFECT | +0.24% | -5.35% | |
| Form 8-K BriaCell Therapeutics For: Jan 30 | SEC filing · Form 8-K | +0.24% | -5.35% | |
| Form S-3 BriaCell Therapeutics | SEC filing · Form S-3 | +0.73% | -1.47% | |
| Form DEF 14A BriaCell Therapeutics For: Jan 09 | SEC filing · Form DEF | +0.00% | -7.68% | |
| Form 8-K BriaCell Therapeutics For: Dec 20 | SEC filing · Form 8-K | -2.63% | -4.30% | |
| Form 10-Q BriaCell Therapeutics For: Oct 31 | SEC filing · Form 10-Q | +0.47% | -3.95% | |
| Form 8-K BriaCell Therapeutics For: Dec 14 | SEC filing · Form 8-K | +0.47% | -3.95% | |
| Form 8-K BriaCell Therapeutics For: Nov 30 | SEC filing · Form 8-K | +1.95% | +3.12% | |
| Form 8-K BriaCell Therapeutics For: Nov 03 | SEC filing · Form 8-K | -1.28% | +9.69% | |
| Form 10-K BriaCell Therapeutics For: Jul 31 | SEC filing · Form 10-K | +0.63% | -9.02% | |
| Form 8-K BriaCell Therapeutics For: Oct 25 | SEC filing · Form 8-K | +0.63% | -9.02% |
Keep exploring
More BCTX: earnings → · analyst actions → · BCTX overview →